About Cristina Larkin
Form D filings for FlightPath Biosciences in 2024 list Cristina Larkin as director.
Cristina Larkin first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Cristina Larkin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Cristina Larkin works with at each company, as listed on that company's latest Form D.
FlightPath Biosciences, Inc. · Form D/A, Oct 24, 2024
CS
Curtis Scribner
Director
MT
Matthew Tindall
President and director